VLA Valneva SE

2.597USD2.363 EUR · EPA-3.55%Mkt Cap: 494.17M USDP/E: —

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese ence…